Sign Up to like & get
recommendations!
0
Published in 2025 at "Scientific Reports"
DOI: 10.1038/s41598-025-15356-3
Abstract: Topical therapies with improved antiviral efficacy, bioavailability, and safety profiles are needed to combat blindness caused by herpes simplex virus type-1 (HSV-1) eye infections. Our previous work demonstrated that micron-sized high porosity activated carbon (HPAC)…
read more here.
Keywords:
drug encapsulated;
carbon;
efficacy;
efficacy bioavailability ... See more keywords